Cytochrome P450 and the individuality of species.

The P450 superfamily is expanding rapidly on many fronts. Arabidopsis genomic sequencing is producing about 2 to 3 novel P450s per week, with some clusters containing 9-14 genes. Bacterial genomes also carry surprises, such as the 20 P450s found in Mycobacterium tuberculosis and the 7 in Bacillus subtilis. The race to finish the human genome has already identified the majority of human P450s, some by expressed sequence tags only. The rapid discovery of new genes is being complemented by detailed analysis of our human genes to identify and characterize the complete set of human P450 polymorphisms and disease-causing mutations, one aspect of our "chemical individuality." Phylogenetic trees are included for plant, fungal, animal, and bacterial P450s. Emphasis is given to the higher order nomenclature of P450 clans, as a tool to see the larger picture of P450 evolution. Arabidopsis is the current record holder in P450 genes, with 186 named genes and a prediction of 350 in the total genome to be completed next year. The biosynthesis of cholesterol in bacteria is discussed in relation to CYP51 as a lanosterol 14 alpha-demethylase. This enzyme may have been the first eukaryotic P450.

[1]  T. Rebbeck.  Modification of Clinical Presentation of Prostate Tumors by a Novel Genetic Variant in CYP3A4 , 1999 .

[2]  N. Lartillot,et al.  Animal evolution. The end of the intermediate taxa? , 1999, Trends in genetics : TIG.

[3]  Michael N. Edmonson,et al.  Reliable identification of large numbers of candidate SNPs from public EST data , 1999, Nature Genetics.

[4]  G. Aithal,et al.  Association of polymorphisms in the cytochrome P450 CYP2C9 with warfarin dose requirement and risk of bleeding complications , 1999, The Lancet.

[5]  R. Feyereisen.  Insect P450 enzymes. , 1999, Annual review of entomology.

[6]  M. Lai,et al.  Detection of a novel cytochrome P-450 1A2 polymorphism (F21L) in Chinese. , 1999, Drug metabolism and disposition: the biological fate of chemicals.

[7]  Cori Bargmann.  Neurobiology of the Caenorhabditis elegans genome. , 1998, Science.

[8]  I. de Waziers,et al.  Detection and characterization of novel polymorphisms in the CYP2E1 gene. , 1998, Pharmacogenetics.

[9]  Jiujiang Yu,et al.  Characterization of the Critical Amino Acids of anAspergillus parasiticus Cytochrome P-450 Monooxygenase Encoded by ordA That Is Involved in the Biosynthesis of Aflatoxins B1, G1, B2, and G2 , 1998, Applied and Environmental Microbiology.

[10]  Zhou,et al.  In search of the first flower: A jurassic angiosperm, archaefructus, from northeast china , 1998, Science.

[11]  D. Kelly,et al.  A sterol biosynthetic pathway in Mycobacterium , 1998, FEBS letters.

[12]  M. Snyder.  Identification of a new cytochrome P450 family, CYP45, from the lobster, Homarus americanus, and expression following hormone and xenobiotic exposures. , 1998, Archives of biochemistry and biophysics.

[13]  P. Danielson,et al.  Induction by alkaloids and phenobarbital of Family 4 Cytochrome P450s in Drosophila : evidence for involvement in host plant utilization , 1998, Molecular and General Genetics MGG.

[14]  B. Barrell,et al.  Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence , 1998, Nature.

[15]  C. Nusbaum,et al.  Large-scale identification, mapping, and genotyping of single-nucleotide polymorphisms in the human genome. , 1998, Science.

[16]  N. M. Brooke,et al.  A molecular timescale for vertebrate evolution , 1998, Nature.

[17]  L. Koymans,et al.  Review Article Cytochromes P450 in fungi , 1998 .

[18]  P. Dayer,et al.  An additional defective allele, CYP2C19*5, contributes to the S-mephenytoin poor metabolizer phenotype in Caucasians. , 1998, Pharmacogenetics.

[19]  A. Child,et al.  Sequence analysis and homology modeling suggest that primary congenital glaucoma on 2p21 results from mutations disrupting either the hinge region or the conserved core structures of cytochrome P4501B1. , 1998, American journal of human genetics.

[20]  T. Kutchan,et al.  Molecular cloning and functional heterologous expression of two alleles encoding (S)-N-methylcoclaurine 3'-hydroxylase (CYP80B1), a new methyl jasmonate-inducible cytochrome P-450-dependent mono-oxygenase of benzylisoquinoline alkaloid biosynthesis. , 1998, The Plant journal : for cell and molecular biology.

[21]  A. Ohta,et al.  Isozyme Function of n-Alkane-inducible Cytochromes P450 in Candida maltosa Revealed by Sequential Gene Disruption* , 1998, The Journal of Biological Chemistry.

[22]  S. McCormick,et al.  Characterization of the gene cluster for biosynthesis of macrocyclic trichothecenes in Myrothecium roridum , 1998, Molecular and General Genetics MGG.

[23]  S. McCormick,et al.  The TRI11 Gene of Fusarium sporotrichioides Encodes a Cytochrome P-450 Monooxygenase Required for C-15 Hydroxylation in Trichothecene Biosynthesis , 1998, Applied and Environmental Microbiology.

[24]  L. Silver.  Genetics goes to Hollywood , 1997, Nature Genetics.

[25]  J. Idle,et al.  A single amino acid substitution (Leu160His) in cytochrome P450 CYP2A6 causes switching from 7-hydroxylation to 3-hydroxylation of coumarin. , 1997, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[26]  C. Crespi,et al.  The R144C change in the CYP2C9*2 allele alters interaction of the cytochrome P450 with NADPH:cytochrome P450 oxidoreductase. , 1997, Pharmacogenetics.

[27]  J. Lafitte,et al.  Polymorphism of the cytochrome P450 CYP2D6 gene in a European population: characterization of 48 mutations and 53 alleles, their frequencies and evolution. , 1997, Pharmacogenetics.

[28]  R. Raff,et al.  Evidence for a clade of nematodes, arthropods and other moulting animals , 1997, Nature.

[29]  D. Bhatnagar,et al.  avnA, a gene encoding a cytochrome P-450 monooxygenase, is involved in the conversion of averantin to averufin in aflatoxin biosynthesis in Aspergillus parasiticus , 1997, Applied and environmental microbiology.

[30]  J. Goldstein,et al.  Differences in the incidence of the CYP2C19 polymorphism affecting the S-mephenytoin phenotype in Chinese Han and Bai populations and identification of a new rare CYP2C19 mutant allele. , 1997, The Journal of pharmacology and experimental therapeutics.

[31]  M. Schuler.  The Role of Cytochrome P450 Monooxygenases in Plant-Insect Interactions , 1996, Plant physiology.

[32]  W. Trager,et al.  Allelic variants of human cytochrome P450 2C9: baculovirus-mediated expression, purification, structural characterization, substrate stereoselectivity, and prochiral selectivity of the wild-type and I359L mutant forms. , 1996, Archives of biochemistry and biophysics.

[33]  G. Shenfield,et al.  The role of the CYP2C9-Leu359 allelic variant in the tolbutamide polymorphism. , 1996, Pharmacogenetics.

[34]  P. Maurel,et al.  Detection of CYP3A5 allelic variant: a candidate for the polymorphic expression of the protein? , 1996, Biochemical and biophysical research communications.

[35]  D W Nebert,et al.  P450 superfamily: update on new sequences, gene mapping, accession numbers and nomenclature. , 1996, Pharmacogenetics.

[36]  B. Kemper,et al.  Substitution at residue 473 confers progesterone 21-hydroxylase activity to cytochrome P450 2C2. , 1995, Molecular pharmacology.

[37]  O Pelkonen,et al.  A genetic polymorphism in coumarin 7-hydroxylation: sequence of the human CYP2A genes and identification of variant CYP2A6 alleles. , 1995, American journal of human genetics.

[38]  John E. Linz,et al.  Comparative mapping of aflatoxin pathway gene clusters in Aspergillus parasiticus and Aspergillus flavus , 1995, Applied and environmental microbiology.

[39]  A. Ohta,et al.  CYP52 (cytochrome P450alk) multigene family in Candida maltosa: identification and characterization of eight members. , 1995, DNA and cell biology.

[40]  D. Nelson,et al.  Diversity and Evolution of Plant P450 and P450-Reductases , 1995, Drug metabolism and drug interactions.

[41]  L. W. Parks,et al.  Physiological implications of sterol biosynthesis in yeast. , 1995, Annual review of microbiology.

[42]  G R Wilkinson,et al.  The major genetic defect responsible for the polymorphism of S-mephenytoin metabolism in humans. , 1994, The Journal of biological chemistry.

[43]  M. Relling,et al.  Identification of a new variant CYP2D6 allele with a single base deletion in exon 3 and its association with the poor metabolizer phenotype. , 1994, Human molecular genetics.

[44]  N. Keller,et al.  Aspergillus nidulans verA is required for production of the mycotoxin sterigmatocystin , 1994, Applied and environmental microbiology.

[45]  L. Wienkers,et al.  Impaired (S)-warfarin metabolism catalysed by the R144C allelic variant of CYP2C9. , 1994, Pharmacogenetics.

[46]  A. Bearn.  Archibald Garrod and the Individuality of Man , 1993 .

[47]  J. S. Miles,et al.  Identification of the primary gene defect at the cytochrome P450 CYP2D locus , 1990, Nature.

[48]  F. Gonzalez,et al.  The CYP2A3 gene product catalyzes coumarin 7-hydroxylation in human liver microsomes. , 1990, Biochemistry.

[49]  D. Nebert,et al.  Evolution of the P450 gene superfamily: animal-plant 'warfare', molecular drive and human genetic differences in drug oxidation. , 1990, Trends in genetics : TIG.

[50]  D. Sanglard,et al.  Characterization of the alkane-inducible cytochrome P450 (P450alk) gene from the yeast Candida tropicalis: identification of a new P450 gene family. , 1989, Gene.

[51]  R. Dawkins.  The Blind Watchmaker , 1986 .

[52]  H. Hayashi,et al.  Presence and synthesis of cholesterol in stable staphylococcal L-forms , 1979, Journal of bacteriology.